Table 2

 Cytokine and chemokines levels in plasma of healthy controls, and in patients with juvenile idiopathic arthritis and diabetes

MediatorControlsOligoarticular JIAPolyarticular JIASystemic JIADiabetes
RemissionActiveRemissionActiveRemissionActive
IFN, interferon; IL, interleukin; JIA, juvenile idiopathic arthritis; MIF, macrophage inhibitory factor; ND, not done; OPG, osteoprotergerin; OSM, oncostatin M; sRANKL, soluble receptor activator of nuclear factor-κ B ligand; TNF, tumour necrosis factor.
*All values (mean (SD)) are expressed in pg/ml (except for those marked **which are expressed in ng/ml).
†Significant difference between controls and patients; p<0.01.
‡Significant difference between disease activity of one specified subtype of JIA compared with all other patients with JIA; p<0.05.
¶Significant difference between disease activity of one specified subtype of JIA compared with all other patients with JIA; p<0.01.
§Significant difference between disease activity of one specified subtype of JIA compared with all other patients with JIA; p<0.001.
**Significant difference between controls and patients; p<0.001.
††Significant difference between controls and patients; p<0.05.
IL1α0.1 (0.0)0.3 (0.3)15 (7.5)0.3 (0.2)22 (21)1.1 (0.9)0.3 (0.2)0.9 (1.6)
IL1β1.2 (0.6)9.9 (8.7)16 (6.3)2.5 (1.6)50 (38)0.7 (0.6)2.5 (1.3)2.3 (13)
IL20.1 (0.1)0.1 (0.1)3.8 (2.3)0.2 (0.2)4.2 (3.9)0.1 (0.1)0.2 (0.1)0.1(0.7)
IL40.0 (0.0)0.2 (0.1)4.6 (1.9)0.1 (0.1)18 (17)0.0 (0.0)1.1 (1.1)0.1 (0.1)
IL50.0 (0.0)0.3 (0.3)2.4 (1.0)1.0 (0.6)32 (31)0.0 (0.0)0.1 (0.1)1.8 (2.0)
IL66 (7.6)116 (101)563 (405)*,†16 (7.0)378 (236)‡7.2 (5.9)29 (13)†22 (38)
IL100.3 (0.3)1.1 (1.0)6.3 (2.2)0.7 (0.4)50 (48)0.5 (0.4)3.7 (2.4)1.2 (1.5)
IL127.5 (2.4)6.6 (4.1)19 (4.2)†15 (12)20 (9.1)†4.3 (3.1)49 (22)‡16 (4.5)
IL131.9 (1.6)3.4 (3.1)17 (7.4)1.3 (1.0)48 (30)0.3 (0.2)3.6 (7.4)0.9 (2.1)
IL150.0 (0.0)0.0 (0.0)0.5 (0.3)0.2 (0.2)2.2 (2.2)0.2 (0.1)0.5 (1.5)0.3 (0.6)
IL170.3 (0.2)0.0 (0.1)425 (241)§0.0 (0.0)100 (94)*1.3 (1.0)0.0 (0.1)0.3 (4.7)
IL18133 (29)153 (51)172 (24)205 (268)194 (60)770 (246)§5622 (1348)§,¶108 (71)
TNFα1.1 (0.6)4.0 (3.6)15 (6.3)4.1 (2.1)20 (17)0.4 (0.3)2.9 (8.2)1.6 (6.2)
IFNγ55 (104)102 (594)201 (100)89 (39)534 (242)54 (34)101 (286)70 (274)
OSM1.6 (0.4)1.9 (1.2)328 (231)4.4 (3.2)18 (12)1.8 (0.5)2.8 (0.9)0.1 (0.4)
MIF**2.3 (0.4)7.4 (2.3)††6.6(1.1)7.6 (1.8)††30 (10)§6.2 (6.9)††15 (3.4)††3.7 (5.6)
CCL220 (10)38 (10)80 (18)34 (12)50 (17)24 (10)8.8 (1.9)69 (39)††
CCL356 (15)85 (39)1416 (378)§,¶440 (225)1099 (749)§,†126 (45)881 (358)§,†168 (31)
CCL5**63 (0.4)63 (7.5)142 (38)56 (12)85 (13)61 (9.2)74 (11)49 (14)
CCL1110 (2.9)55 (26)80 (24)60 (24)44 (16)26 (13)6.3 (2.5)15 (14)
CCL1744 (24)109 (47)107 (23)33 (8.8)65 (16)97 (31)44 (24)61 (46)
CCL18**40 (5.2)24 (5.0)49 (15.2)35 (6.6)47 (23)29 (8.5)42 (8.7)36 (11)
CCL22389 (52)1378 (1009)1703 (385)483 (129)1430 (758)452 (112)1264 (911)233 (139)
CXCL80.2 (0.1)284 (263)287 (249)23 (15)71 (44)0.1 (0.5)2.4 (1.9)104 (36)*
CXCL98.4 (3.0)34 (29)127 (54)*,††22 (11)102 (50)*,††1.8 (0.9)41 (24)††,†6.3 (10)
CXCL1098 (36)171 (65)828 (216)§,†289 (119)442 (130)*,¶70 (29)137 (45)††,†242 (105)††
OPG**0.7 (0.5)0.8 (0.5)5.9 (2.6)0.4 (0.2)2.4 (1.6)1.7 (0.5)††2.8 (2.2)2.4 (1.5)
sRANKL0.9 (0.4)0.3 (0.1)3.2 (2.8)1.5 (0.9)30 (28)3.9 (3.4)1.2 (0.7)0.8 (1.3)
sCD54**159 (5.9)145 (10)158 (24)185 (134)173 (24)161 (14)228 (44)131 (27)
sCD106**566 (31)776 (177)739 (63)733 (63)984 (299)656 (58)723 (104)542 (91)